Your browser doesn't support javascript.
Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS-CoV-2 vaccine.
Xu, Xingli; Liao, Yun; Jiang, Guorun; Yao, Weiguo; Duan, Suqin; Xiao, Kang; Ding, Xuefeng; Zhao, Heng; Zhang, Yujian; Zhang, Aihua; Yang, Jingsi; Che, Yanchun; Zhang, Jun; Zhao, Fanfan; Ma, Xiaopin; Zhao, Zhimei; Cui, Pingfang; Yang, Xiaolei; Lin, Xiaorui; Cai, Wei; Yan, Jiao; Yang, Zhenqing; Qiu, Heng; Zhang, Jing; Huang, Lei; Shen, Mingyun; Zhao, Guofeng; Yu, Li; Li, Dandan; Fan, Shengtao; Zhang, Ying; Wang, Lichun; He, Licun; Dong, Fei; Xu, Wenbo; Li, Hangwen; Li, Qihan.
  • Xu X; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Liao Y; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Jiang G; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Yao W; Stemirna Therapeutics Co., Ltd., Shanghai, China.
  • Duan S; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Xiao K; National Institute for Viral Disease Control and Prevention, China CDC, Beijing, China.
  • Ding X; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Zhao H; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Zhang Y; Stemirna Therapeutics Co., Ltd., Shanghai, China.
  • Zhang A; Stemirna Therapeutics Co., Ltd., Shanghai, China.
  • Yang J; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Che Y; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Zhang J; Stemirna Therapeutics Co., Ltd., Shanghai, China.
  • Zhao F; Stemirna Therapeutics Co., Ltd., Shanghai, China.
  • Ma X; Stemirna Therapeutics Co., Ltd., Shanghai, China.
  • Zhao Z; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Cui P; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Yang X; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Lin X; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Cai W; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Yan J; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Yang Z; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Qiu H; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Zhang J; Stemirna Therapeutics Co., Ltd., Shanghai, China.
  • Huang L; Stemirna Therapeutics Co., Ltd., Shanghai, China.
  • Shen M; Stemirna Therapeutics Co., Ltd., Shanghai, China.
  • Zhao G; Stemirna Therapeutics Co., Ltd., Shanghai, China.
  • Yu L; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Li D; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Fan S; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Zhang Y; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Wang L; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • He L; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Dong F; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
  • Xu W; National Institute for Viral Disease Control and Prevention, China CDC, Beijing, China.
  • Li H; Stemirna Therapeutics Co., Ltd., Shanghai, China.
  • Li Q; Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, 650118, China.
Clin Transl Med ; 12(6): e875, 2022 06.
Article in English | MEDLINE | ID: covidwho-1881402
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies Topics: Vaccines Limits: Humans Language: English Journal: Clin Transl Med Year: 2022 Document Type: Article Affiliation country: Ctm2.875

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies Topics: Vaccines Limits: Humans Language: English Journal: Clin Transl Med Year: 2022 Document Type: Article Affiliation country: Ctm2.875